Wells Fargo’s MediciNova MNOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-383
| Closed | -$555 | – | 7246 |
|
|
2024
Q1 | $555 | Buy |
383
+6
| +2% | +$9 | ﹤0.01% | 6262 |
|
|
2023
Q4 | $566 | Buy |
377
+19
| +5% | +$34 | ﹤0.01% | 6354 |
|
|
2023
Q3 | $748 | Buy |
358
+5
| +1% | +$12 | ﹤0.01% | 6267 |
|
|
2023
Q2 | $812 | Buy |
353
+14
| +4% | +$31 | ﹤0.01% | 6374 |
|
|
2023
Q1 | $732 | Buy |
339
+5
| +1% | +$11 | ﹤0.01% | 6465 |
|
|
2022
Q4 | $685 | Buy |
334
+8
| +2% | +$18 | ﹤0.01% | 6296 |
|
|
2022
Q3 | $1K | Sell |
326
-2
| -0.6% | -$5 | ﹤0.01% | 6396 |
|
|
2022
Q2 | $1K | Buy |
328
+26
| +9% | +$68 | ﹤0.01% | 6552 |
|
|
2022
Q1 | $1K | Sell |
302
-18
| -6% | -$44 | ﹤0.01% | 6828 |
|
|
2021
Q4 | $1K | Buy |
+320
| New | +$1.07K | ﹤0.01% | 7036 |
|
|
2021
Q2 | – | Sell |
-89,143
| Closed | -$450K | – | 7228 |
|
|
2021
Q1 | $450K | Sell |
89,143
-16,711
| -16% | -$97.2K | ﹤0.01% | 4739 |
|
|
2020
Q4 | $557K | Buy |
105,854
+62,284
| +143% | +$357K | ﹤0.01% | 4447 |
|
|
2020
Q3 | $228K | Sell |
43,570
-6,451
| -13% | -$37.2K | ﹤0.01% | 4897 |
|
|
2020
Q2 | $271K | Buy |
50,021
+20,536
| +70% | +$109K | ﹤0.01% | 4725 |
|
|
2020
Q1 | $110K | Buy |
29,485
+1,394
| +5% | +$7.25K | ﹤0.01% | 5014 |
|
|
2019
Q4 | $189K | Sell |
28,091
-36,748
| -57% | -$276K | ﹤0.01% | 4986 |
|
|
2019
Q3 | $516K | Buy |
64,839
+7,074
| +12% | +$63.1K | ﹤0.01% | 4350 |
|
|
2019
Q2 | $556K | Sell |
57,765
-2,746
| -5% | -$28.9K | ﹤0.01% | 4306 |
|
|
2019
Q1 | $501K | Sell |
60,511
-938
| -2% | -$8.18K | ﹤0.01% | 4329 |
|
|
2018
Q4 | $503K | Buy |
61,449
+5,235
| +9% | +$52.2K | ﹤0.01% | 4341 |
|
|
2018
Q3 | $702K | Buy |
56,214
+1,320
| +2% | +$13.3K | ﹤0.01% | 4205 |
|
|
2018
Q2 | $437K | Buy |
54,894
+1,974
| +4% | +$20.4K | ﹤0.01% | 4556 |
|
|
2018
Q1 | $542K | Buy |
52,920
+7,570
| +17% | +$75.4K | ﹤0.01% | 4334 |
|
|
2017
Q4 | $294K | Buy |
45,350
+12,775
| +39% | +$84.7K | ﹤0.01% | 4764 |
|
|
2017
Q3 | $208K | Buy |
32,575
+12,624
| +63% | +$67.1K | ﹤0.01% | 4909 |
|
|
2017
Q2 | $105K | Hold |
19,951
| – | – | ﹤0.01% | 5147 |
|
|
2017
Q1 | $120K | Hold |
19,951
| – | – | ﹤0.01% | 5118 |
|
|
2016
Q4 | $120K | Buy |
19,951
+9,951
| +100% | +$70.1K | ﹤0.01% | 5056 |
|
|
2016
Q3 | $75K | Hold |
10,000
| – | – | ﹤0.01% | 5083 |
|
|
2016
Q2 | $76K | Buy |
10,000
+9,600
| +2,400% | +$69.4K | ﹤0.01% | 4985 |
|
|
2016
Q1 | $3K | Buy |
+400
| New | +$1.98K | ﹤0.01% | 5967 |
|
|
2014
Q2 | – | Sell |
-45,026
| Closed | -$92K | – | 6218 |
|
|
2014
Q1 | $92K | Hold |
45,026
| – | – | ﹤0.01% | 4689 |
|
|
2013
Q4 | $96K | Hold |
45,026
| – | – | ﹤0.01% | 4539 |
|
|
2013
Q3 | $116K | Hold |
45,026
| – | – | ﹤0.01% | 4430 |
|
|
2013
Q2 | $118K | Buy |
+45,026
| New | +$133K | ﹤0.01% | 4343 |
|
Other funds holding MNOV
EWM
BCM
Wells Fargo's MNOV Position: Q2 2024 in Review
Wells Fargo sold out of MediciNova (MNOV) in Q2 2024, closing a stake of 383 shares — an estimated $555 sold.
Wells Fargo first reported a position in MNOV in Q2 2013 and held it in 35 quarters. The position peaked at $702K in Q3 2018. 33 funds tracked by Wall St. Rank hold MNOV as of Q2 2024.
- Wells Fargo reported no remaining MediciNova position as of Q2 2024 after selling out during the quarter.
- Wells Fargo sold 383 MediciNova shares in Q2 2024, an estimated $555.
- Wells Fargo first reported a position in MediciNova in Q2 2013 and held it in 35 quarters.
- Wells Fargo's MediciNova position peaked at $702K in Q3 2018.
- 33 funds tracked by Wall St. Rank held MediciNova as of Q2 2024.
Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.